Extreme Drug Resistance Assay for Stomach Cancer
Learn More About Stomach Cancer Extreme Drug Resistance: Chat with Us | Email Us
Stomach Cancer: Extreme Drug Resistance
Designed for solid cancer tumors, the Extreme Drug Resistance (EDR) Assay (or chemoresistance) is a highly accurate test which determines how resistant your stomach cancer tumor may be to specific chemotherapeutic drugs. If tumor cells grow in the presence of extreme drug exposure, it indicates the likeliness that your tumor may be resistant to the chemotherapy drug.
By better understanding how your body may respond to chemo drugs, medical oncologists at CTCA can avoid unnecessary toxicity and consider other protocols for your stomach cancer treatment.
Next Topic: MRI for Stomach Cancer

